DAE HWA Pharmaceutical Co., Ltd. (KOSDAQ:067080)

South Korea flag South Korea · Delayed Price · Currency is KRW
16,250
+1,440 (9.72%)
At close: Mar 28, 2025, 3:30 PM KST
55.35%
Market Cap 284.65B
Revenue (ttm) 115.31B
Net Income (ttm) 10.76B
Shares Out 17.52M
EPS (ttm) 617.61
PE Ratio 26.31
Forward PE n/a
Dividend 150.00 (0.92%)
Ex-Dividend Date Dec 27, 2024
Volume 10,503,554
Average Volume 4,105,598
Open 14,950
Previous Close 14,810
Day's Range 14,680 - 17,740
52-Week Range 8,290 - 24,150
Beta 0.17
RSI 65.62
Earnings Date Mar 17, 2025

About DAE HWA Pharmaceutical

DAE HWA Pharmaceutical Co., Ltd., a pharmaceutical company, produces and supplies pharmaceutical products in South Korea. The company offers drugs for anticancer, antibiotics, antifungal and skin ailment, antivirus, anti-allergosis, hemorrhoids, antidepressant, antiepileptic, psychotropic agent, anti respiratory, anti-inflammatory, analgesic, skeletal muscle relaxants, osteoporosis, anti-arthritis, gastro-intestinal, obesity, antispasmodic, diabetics, hypertension, hyperlipemia, antithrombotic and anticoagulant, hepatic, erectile dysfunction, u... [Read more]

Industry Pharmaceutical Preparations
Founded 1984
Employees 308
Stock Exchange KOSDAQ
Ticker Symbol 067080
Full Company Profile

Financial Performance

In 2019, DAE HWA Pharmaceutical's revenue was 114.61 billion, an increase of 4.06% compared to the previous year's 110.14 billion. Earnings were 10.54 billion, an increase of 58.55%.

Financial Statements

News

There is no news available yet.